Precision System Science Co Stock

Precision System Science Co Liabilities

The The Liabilities of Precision System Science Co (7707.T) as of Jul 22, 2026 is 1.18 B JPY. In the previous year, The Liabilities was 2.25 B JPY — a change of -47.78% (lower).

Liabilities

1.18 BJPY

YoY

-47.78%

Last updated:

In 2026, Precision System Science Co's total liabilities amounted to 1.18 B JPY, a -47.78% difference from the 2.25 B JPY total liabilities in the previous year.

Access this data via the Eulerpool API

Precision System Science Co Stock analysis

What does Precision System Science Co do? Precision System Science Co Ltd is a leading company in the field of medical research and diagnostics, founded in Japan in 1989. The company is headquartered in Chiba, Japan and operates branches in Europe, the USA, and Asia. Its business model is focused on providing a wide range of instruments, devices, and services for research, diagnostics, and therapy in the medical industry. The company designs and produces its own products and also offers customized solutions for customers. It is divided into different divisions, including instruments and devices for molecular biology and diagnostics, cell analysis, microscopy, and sample processing. They offer products such as PCR systems, qPCR systems, automated sample preparation systems, and RNA isolation kits for molecular biology and diagnostics. They also produce cell counting systems, flow cytometers, high-speed imaging systems, multi-well plate readers for cell analysis. In the microscopy division, the company manufactures high-quality fluorescence microscopes and deconvolution microscopes for protein and DNA molecule analysis, disease diagnostics, drug development, etc. In the sample processing division, they produce automated stations used for preparing samples for genomics and proteomics analysis. The company is also engaged in research and development of medical devices and instruments to improve the quality of medical diagnostics and therapy. A successful product example is the qPCR thermocycler MIQE used in the diagnosis and therapy of diseases like cancer. Precision System Science Co Ltd has played a significant role in fighting the COVID-19 pandemic by producing test kits for diagnosis and offering advanced PCR systems for mass testing. They are committed to continuous innovation and improvement of their products and services to meet the changing needs of the medical industry. With their strong presence and dedication to providing state-of-the-art and innovative products and services, they will remain a major player in the global market for medical devices and instruments. Precision System Science Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Precision System Science Co's Liabilities

Precision System Science Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Precision System Science Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Precision System Science Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Precision System Science Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Precision System Science Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Precision System Science Co stock

The Liabilities of Precision System Science Co is 1.18 B JPY in 2026.

Access this data via the Eulerpool API

Balance Sheet — Precision System Science Co

All Key Metrics — Precision System Science Co